Search results for "bowel"

showing 10 items of 637 documents

Letter: psoriasiform eruption during vedolizumab therapy

2019

medicine.medical_specialtyHepatologybusiness.industryGastroenterologyInflammatory Bowel DiseasesAntibodies Monoclonal HumanizedInflammatory Bowel Diseasesmedicine.diseaseDermatologyVedolizumabPsoriasiform eruptionPsoriasisMonoclonalHumansPsoriasisMedicinePharmacology (medical)Registriespsoriasiform eruption vedolizumabbusinessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities

2017

medicine.medical_specialtyHepatologybusiness.industryPneumonia PneumocystisPNEUMOCYSTIS JIROVECIGastroenterologyInflammatory Bowel DiseasesPneumocystis cariniimedicine.diseaseInflammatory bowel diseaseGastroenterology03 medical and health sciencesPneumonia0302 clinical medicine030228 respiratory systemConcomitantInternal medicineHumansMedicine030211 gastroenterology & hepatologybusinessClinical Gastroenterology and Hepatology
researchProduct

Tu1320 Personality Traits, Defense Mechanisms and Perception of Quality of Life (QOL) in Patients With Inflammatory Bowel Disease (IBD) and Matched C…

2012

medicine.medical_specialtyHepatologybusiness.industrymedia_common.quotation_subjectGastroenterologyDefence mechanismsmedicine.diseaseInflammatory bowel diseaseQuality of lifePerceptionMedicinePersonalityIn patientBig Five personality traitsbusinessPsychiatrymedia_commonGastroenterology
researchProduct

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of …

2017

Abstract The two main forms of intestinal bowel disease, namely ulcerative colitis and Crohn’s disease, are not curable but can be controlled by various medical therapies. The Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) has prepared clinical practice guidelines to help physicians prescribe corticosteroids and immunosuppressive drugs for these patients. The guidelines consider therapies that induce remission in patients with active disease as well as treatment regimens that maintain remission. These guidelines complement already existing guidelines from IG-IBD on the use of biological drugs in patients with inflammatory bowel diseases.

medicine.medical_specialtyIBDDiseaseGuidelineGuidelinesInflammatory bowel diseaseGastroenterologyBiological drugs03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicineMedicalmedicineCorticosteroidCorticosteroidsHumansIn patient030212 general & internal medicineCorticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis; Hepatology; GastroenterologySocieties MedicalCrohn's diseaseSettore MED/12 - GastroenterologiaUlcerative colitiHepatologybusiness.industryImmunosuppressorsRemission InductionGastroenterologyInflammatory Bowel Diseasesmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisdigestive system diseasesClinical PracticeCrohn's diseaseUlcerative colitisItalyImmunosuppressorCorticosteroids; Crohn's disease; Guidelines; IBD; Immunosuppressors; Ulcerative colitis; Adrenal Cortex Hormones; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Italy; Remission Induction; Societies Medical030211 gastroenterology & hepatologybusinessSocietiesImmunosuppressive Agents
researchProduct

MP-07.06

2006

medicine.medical_specialtyIleocecal valvemedicine.anatomical_structurebusiness.industryUrologyUrinary systemmedicineIn patientBowel functionbusinessContinent Urinary DiversionSurgeryUrology
researchProduct

Clinical implications of mucosal healing in the management of patients with inflammatory bowel disease

2013

AbstractThe natural history of Crohn's Disease and ulcerative colitis is characterized by repeated episodes of inflammation and ulceration of the bowel. This results in complications implying a worse quality of life and significant healthcare costs, due to hospitalization, surgery and an escalation of therapy.The main goal of the therapy in inflammatory bowel disease is to achieve and maintain disease remission, with an improved health-related quality of life, less hospitalization, and less surgery. The concept of remission has changed in the recent years. In fact the concept of clinical remission, where only the patients’ symptoms are in remission, has been replaced by the new concept of d…

medicine.medical_specialtyInflammationDiseaseClinical remissionInflammatory bowel diseaseGastroenterologyEndoscopy GastrointestinalMaintenance ChemotherapyBiological drugsCrohn DiseaseQuality of lifeRecurrenceInternal medicinemedicineHumansIntestinal MucosaWound HealingHepatologybusiness.industryMucosal healingInflammatory Bowel DiseaseRemission InductionGastroenterologymedicine.diseaseUlcerative colitisNatural historyMucosal healingColitis Ulcerativemedicine.symptombusinessDigestive and Liver Disease
researchProduct

Computed tomography of bowel obstruction: Tricks of the trade

2015

Bowel obstruction (BO) is a frequent cause of hospitalization and surgical consultation for acute abdominal pain. It is usually suspected at physical examination, but clinical and laboratory data are often nonspecific. Thus, computed tomography plays a crucial role in a correct diagnosis of BO. Indeed, computed tomography can confirm a diagnosis of BO, and identify the location and cause of the obstruction. In this review, the computed tomography appearances of common and uncommon causes of BO and pseudo-obstruction are reviewed.

medicine.medical_specialtyIntestinal NeoplasmHerniaColonAcute abdominal painTissue AdhesionsPhysical examinationComputed tomographyPeritoneal DiseasesBezoarsbowel pseudo-obstructionCrohn Diseasesmall bowelIntestinal NeoplasmsHumansMedicinebowel obstructionDiverticulitisDiverticulitimedicine.diagnostic_testHepatologybusiness.industryMedicine (all)Intestinal Pseudo-ObstructionGastroenterologymedicine.diseaseBezoarBowel obstructionTissue AdhesionPeritoneal DiseaseRadiologybusinessTomography X-Ray ComputedIntussusceptionIntestinal ObstructionCTHuman
researchProduct

Bowel resection reduces aortic pulse wave velocity in patients with ulcerative colitis. A longitudinal study.

2020

NA

medicine.medical_specialtyLongitudinal studySettore MED/09 - Medicina Internamedicine.medical_treatmentInflammationBlood PressurePulse Wave AnalysisInflammatory bowel diseaseGastroenterologyInflammatory bowel diseaseVascular StiffnessInternal medicineInternal MedicinemedicineHumansIn patientLongitudinal StudiesPulse wave velocityArterial stiffness Inflammation Inflammatory bowel disease Pulse wave velocity Blood Flow Velocity Blood Pressure Humans Longitudinal Studies Pulse Wave Analysis Colitis Ulcerative Vascular StiffnessInflammationbusiness.industryBowel resectionmedicine.diseaseUlcerative colitisArterial stiffnessPulse wave velocityArterial stiffnessColitis Ulcerativemedicine.symptombusinessBlood Flow VelocityEuropean journal of internal medicine
researchProduct

Octreotide for malignant bowel obstruction: Twenty years after

2012

Malignant bowel obstruction (MBO) is a challenging complication of advanced cancer. Conservative treatment of inoperable MBO in terminal cancer patients has been found to be effective in controlling the distressing symptoms caused by this complication in inoperable cancer patients. Twenty years ago, octreotide was proposed to treat symptoms related to malignant bowel obstruction. Since then several reports have confirmed the efficacy of octreotide in the management of gastrointestinal symptoms of MBO. Fifteen randomized controlled trials or observational reports with a significant number of patients treated with octreotide have been reviewed; 281 patients were surveyed. Authors reported a t…

medicine.medical_specialtyOctreotideOctreotidelaw.inventionGastrointestinal AgentsRandomized controlled triallawNeoplasmsHumansMedicineNeoplasm StagingGastrointestinal agentbusiness.industryCancerHematologymedicine.diseaseAdvanced cancerSurgeryBowel obstructionTreatment OutcomeOncologyObservational studybusinessComplicationIntestinal Obstructionmedicine.drugCritical Reviews in Oncology/Hematology
researchProduct

Therapeutic alternatives in the management of osteoradionecrosis of the jaws. Systematic review

2020

Background to systematically review the literature, comparing the healing of osteoradionecrosis (ORN) among the therapeutic alternatives: surgical, pharmacological and combined. Material and Methods The review was organized according to the PRISMA protocol with regards to the following PICO question: patients with ORN of the jaws (P=Patient); all interventions reported (I = intervention); between all therapies (C=Comparison); healing of lesions (O=outcome). Results Surgical treatment was the most common choice (46.3%) followed by pharmacological treatment, exclusively (25.9%) or combined (26.9%). Treatment exclusively by surgical intervention seems to be most effective option, with 51.2% of…

medicine.medical_specialtyOsteoradionecrosismedicine.medical_treatmentPsychological interventionMEDLINEcrohn?s diseaseReviewPharmacological treatment03 medical and health sciences0302 clinical medicineinflammatory bowel diseaseIntervention (counseling)medicineHumansSurgical treatmentGeneral DentistryLow level laser therapyUNESCO:CIENCIAS MÉDICASulcerative colitisbusiness.industry030206 dentistryapical periodontitisPrognosismedicine.diseaseSurgeryJawOsteoradionecrosisOtorhinolaryngologyHead and Neck Neoplasmstoot canal treatmentSurgeryOral SurgerybusinessJaw Diseases
researchProduct